Literature DB >> 10920146

The influence of intrapartum antibiotics on the clinical spectrum of early-onset group B streptococcal infection in term infants.

P Bromberger1, J M Lawrence, D Braun, B Saunders, R Contreras, D B Petitti.   

Abstract

OBJECTIVE: The use of intrapartum antibiotics to prevent early-onset group B streptococcal (EOGBS) infection has left pediatricians in a quandary about the appropriate evaluation and treatment of infants at risk for this infection. The aim of this study was to determine whether intrapartum antibiotic prophylaxis changed the constellation and timing of onset of clinical signs of group B streptococcal (GBS) infection in term infants.
METHODOLOGY: We conducted a retrospective chart review of infants who had EOGBS infection and were born in Southern California Kaiser Permanente Hospitals from 1988 through 1996. Objective criteria were used to ascertain maternal risk of infection, intrapartum antibiotic prophylaxis, and onset of clinical signs of infection.
RESULTS: Three hundred nineteen infants with EOGBS sepsis, bacteremia, or clinically suspected infection were identified from a population of 277 912 live births. Of the 172 term infants with culture-positive infection who had clinical signs of infection, 95% exhibited them in the first 24 hours of life. All of the infants exposed to intrapartum antibiotics became ill within the first 24 hours of life.
CONCLUSIONS: Exposure to antibiotics during labor did not change the clinical spectrum of disease or the onset of clinical signs of infection within 24 hours of birth for term infants with EOGBS infection. A 48-hour stay is not required to monitor asymptomatic term infants exposed to intrapartum antibiotics for onset of GBS infection.

Entities:  

Mesh:

Year:  2000        PMID: 10920146     DOI: 10.1542/peds.106.2.244

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  11 in total

1.  Estradiol and progesterone strongly inhibit the innate immune response of mononuclear cells in newborns.

Authors:  Eric Giannoni; Laurence Guignard; Marlies Knaup Reymond; Matthieu Perreau; Matthias Roth-Kleiner; Thierry Calandra; Thierry Roger
Journal:  Infect Immun       Date:  2011-04-25       Impact factor: 3.441

Review 2.  Reappraisal of guidelines for management of neonates with suspected early-onset sepsis.

Authors:  William E Benitz; James L Wynn; Richard A Polin
Journal:  J Pediatr       Date:  2015-01-29       Impact factor: 4.406

3.  Stratification of risk of early-onset sepsis in newborns ≥ 34 weeks' gestation.

Authors:  Gabriel J Escobar; Karen M Puopolo; Soora Wi; Benjamin J Turk; Michael W Kuzniewicz; Eileen M Walsh; Thomas B Newman; John Zupancic; Ellice Lieberman; David Draper
Journal:  Pediatrics       Date:  2013-12-23       Impact factor: 7.124

4.  Management of term infants at increased risk for early-onset bacterial sepsis.

Authors:  Ann L Jefferies
Journal:  Paediatr Child Health       Date:  2017-06-15       Impact factor: 2.253

5.  Naturally occurring disseminated group B streptococcus infections in postnatal rats.

Authors:  Katherine A Shuster; Gerald A Hish; Lindsi A Selles; Mahboob A Chowdhury; Roger C Wiggins; Robert C Dysko; Ingrid L Bergin
Journal:  Comp Med       Date:  2013-02       Impact factor: 0.982

Review 6.  Risk assessment in neonatal early onset sepsis.

Authors:  Sagori Mukhopadhyay; Karen M Puopolo
Journal:  Semin Perinatol       Date:  2012-12       Impact factor: 3.300

7.  Population-based study of early-onset neonatal sepsis in Canada.

Authors:  Michael Sgro; Anna Kobylianskii; Mark H Yudin; Dat Tran; Julia Diamandakos; Jonathan Sgro; Douglas M Campbell
Journal:  Paediatr Child Health       Date:  2018-04-24       Impact factor: 2.253

8.  Management of the infant at increased risk for sepsis.

Authors: 
Journal:  Paediatr Child Health       Date:  2007-12       Impact factor: 2.253

9.  Association between antibodies against group B Streptococcus surface proteins and recto-vaginal colonisation during pregnancy.

Authors:  Sonwabile Dzanibe; Gaurav Kwatra; Peter V Adrian; Sheila Z Kimaro-Mlacha; Clare L Cutland; Shabir A Madhi
Journal:  Sci Rep       Date:  2017-11-28       Impact factor: 4.379

10.  Duration of intrapartum antibiotics for group B streptococcus on the diagnosis of clinical neonatal sepsis.

Authors:  Mark A Turrentine; Anthony J Greisinger; Kimberly S Brown; Oscar A Wehmanen; Melanie E Mouzoon
Journal:  Infect Dis Obstet Gynecol       Date:  2013-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.